HOME
ABOUT
SCIENCE
PATIENTS
NEWS
CAREERS
Vitalgen Values
Vitalgen Leadership
Vitalgen Culture
Technology Platforms
Disease Areas and Research Pipeline
VGB-R04
VGB-R01
ABOUT
SCIENCE
PATIENTS
中文
EN
HOME
ABOUT
SCIENCE
PATIENTS
NEWS
CAREERS
News
Milestone! Vitalgen closed its Angel funding round
2020-06-23
(Shanghai, China, June 23, 2020), Shanghai Vitalgen BioPharma Co., Ltd. Closed its Angel funding round. This round is led by IDG, with participation from Apricot Capital.
Prev: Vitalgen closed 300 million RMB Series A funding round
Next: No more
Return